ClinicalTrials.Veeva

Menu

Improvement in Wound Healing With Negative Pressure Wound Therapy for Postoperative Total Hip Arthroplasty

University of North Carolina (UNC) logo

University of North Carolina (UNC)

Status

Terminated

Conditions

Wound Complication
Complications; Arthroplasty, Infection or Inflammation

Treatments

Device: PREVENA

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT02355691
14-1920

Details and patient eligibility

About

For the target population of adult patients following primary total hip arthroplasty, the randomized clinical trial will be used to evaluate the efficacy of the use of a mobile negative pressure wound therapy(NPWT) device compared to a standard absorptive dressing in the immediate postoperative period. We will apply two dressing types and evaluate the postoperative wounds with a wound scoring system (ASEPSIS) that incorporates multiple variables of wound infection risk.

Enrollment

16 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients undergoing primary total hip arthroplasty.

Exclusion criteria

  • age less than 18 y/o
  • Total hip arthroplasty for fracture
  • Revision or conversion total hip arthroplasty
  • inability to personally consent to participation due to cognitive impairment, intoxication or sedation
  • multiple surgical procedures
  • Patients taking immune modulating medication(prednisone, methotrexate, anakinra, etc.)
  • skin hypersensitivity to acrylic adhesive or silver.
  • Inability to care for dressing due to physical or mental incapacitation

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

16 participants in 2 patient groups

PREVENA Group
Experimental group
Description:
Patients will be treated with the PREVENA negative pressure device following total hip arthroplasty. This dressing will be used for a period of seven days.
Treatment:
Device: PREVENA
Standard group
No Intervention group
Description:
Patients will be treated with the standard absorptive dressing following total hip arthroplasty.

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems